With Great Sorrow We Announce the Passing of Prof. Parttaporn Isarangkura: A Pioneer in Hemophilia Care in Thailand and Beyond
Brian O Mahony, CEO of Irish Haemophilia Society, has shared a devastating news announcement about Parttaporn Isarangkura on X:
”It was with deep sadness that I learned today of the passing of Prof. Parttaporn Isarangkura from Bangkok, Thailand. Dr. Pat as we referred to her was a very renowned and major figure in the medical and bleeding disorders community in Thailand – WFH.”
It is with great regret that we announce the passing of Professor Parttaporn Isarangkura, a visionary leader who transformed hemophilia care in Thailand—introducing platelet concentrates for dengue fever, cryoprecipitate for hemophilia, and spearheading HIV antigen testing.
As national lead for hemophilia services, she implemented strategic, lasting improvements with grace, determination, and quiet strength.
A mentor across ASEAN and a key figure in the success of the 2004 WFH Global Congress in Thailand, Dr. Pat’s legacy is one of diplomacy, impact, and unwavering dedication.

The latest news in the field of bleeding and thrombosis featured in Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia
